Arteriosclerosis
Not recruitingStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
- Disease:Arteriosclerosis
- Substances:Inclisiran
Italy- Participants:18–64 years · 65+ years
- Substances:Inclisiran
- Sponsor:Novartis Pharma AG
Rare diseases
Investigational molecules
Locations
Back to Italy282 clinical trials in Perugia, Italy across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on lung cancer, leukemia, and breast cancer treatments. Studies include evaluating new combination therapies and targeted treatments for various cancer types.
Multiple trials are investigating breakthrough treatments for both early-stage and metastatic cancers.
Research focusing on chronic skin conditions, including allergic contact dermatitis, hidradenitis suppurativa, and prurigo nodularis.
Trials aim to improve diagnostic methods and develop targeted therapies for persistent skin conditions.
Studies examining treatments for various autoimmune conditions, including psoriatic arthritis and non-infectious uveitis.
Research focuses on developing more effective treatments with fewer side effects for chronic autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.